Bevacizumab: a new potential therapeutic option in sinusoidal obstruction syndrome

Asian Pac J Cancer Prev. 2011;12(8):2147-8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Bevacizumab
  • Hepatic Veno-Occlusive Disease / drug therapy*
  • Hepatic Veno-Occlusive Disease / pathology
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Bevacizumab